Welcure Drugs — 360° view

Welcure Drugs, a company in the Pharmaceuticals industry, reported revenue of ₹66 crore and net profit of ₹8.00 crore for the September 2025 quarter.

Welcure Drugs (BSE: WELCURE) closed at ₹0.18 on 20 Nov 2026, down 67.9% over the past year. Its market capitalisation is ₹22 crore.

Share price
₹0.18 (20 Nov 2026)
Market cap
₹22 Cr (20 Nov 2026)
Revenue
₹66 Cr (September 2025 quarter)
Net profit
₹8 Cr (September 2025 quarter)
ROCE
-3.40% (FY26)
ROE
-5.50% (FY26)
Book value
₹0.78 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹0.59 / ₹0.17 (20 Nov 2026)
1-year return
-67.9% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: WELCURE

Incorporated in 1992, Welcure Drugs and Pharmaceuticals Ltd is in the business of pharmaceutical and healthcare.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.